Objective evaluation of the response of infantile haemangiomas to propranolol treatment using a three-dimensional imaging system
- PMID: 30919412
- DOI: 10.1111/bjd.17925
Objective evaluation of the response of infantile haemangiomas to propranolol treatment using a three-dimensional imaging system
References
-
- Hartzell LD, Buckmiller LM. Current management of infantile hemangiomas and their common associated conditions. Otolaryngol Clin N Am 2012; 45:545-56.
-
- Chang LC, Haggstrom AN, Drolet BA et al. Growth characteristics of infantile hemangiomas: implications for managements. Pediatrics 2008; 122:360-7.
-
- Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163:269-74.
-
- Hermans DJ, Bauland CG, Zweegers J et al. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions. Br J Dermatol 2013; 168:837-43.
-
- Dyer JA. Practice gaps. Propranolol to treat hemangiomas of infancy: safety and side effect recognition. JAMA Dermatol 2013; 149:485-6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical